Overall survival after immunotherapy, tyrosine kinase inhibitors and surgery in treatment of metastatic renal cell cancer: outcome of 143 consecutive patients from a single centre

Research output: Contribution to journalJournal articleResearchpeer-review

  • Trine Honnens de Lichtenberg
  • Gregers G. Hermann
  • Mikael Rorth
  • Mari-Janne Hojer Larsen
  • Zahra Mansourvar
  • Mette L. Holm
  • Scheike, Thomas
Original languageEnglish
JournalScandinavian Journal of Urology and Nephrology
Issue number4
Pages (from-to)379-386
Publication statusPublished - Aug 2014

    Research areas

  • immunotherapy, metastasectomy, metastatic renal cancer, prognosis, risk groups, tyrosine kinase inhibitors

ID: 135266649